Nctid:
NCT00000444
Payload:
{"hasResults"=>false, "derivedSection"=>{"miscInfoModule"=>{"versionHolder"=>"2024-09-05"}, "conditionBrowseModule"=>{"meshes"=>[{"id"=>"D000000437", "term"=>"Alcoholism"}], "ancestors"=>[{"id"=>"D000019973", "term"=>"Alcohol-Related Disorders"}, {"id"=>"D000019966", "term"=>"Substance-Related Disorders"}, {"id"=>"D000064419", "term"=>"Chemically-Induced Disorders"}, {"id"=>"D000001523", "term"=>"Mental Disorders"}], "browseLeaves"=>[{"id"=>"M3783", "name"=>"Alcoholism", "asFound"=>"Alcoholism", "relevance"=>"HIGH"}, {"id"=>"M21842", "name"=>"Alcohol-Related Disorders", "relevance"=>"LOW"}, {"id"=>"M21837", "name"=>"Substance-Related Disorders", "relevance"=>"LOW"}, {"id"=>"M30302", "name"=>"Chemically-Induced Disorders", "relevance"=>"LOW"}, {"id"=>"M4815", "name"=>"Mental Disorders", "relevance"=>"LOW"}, {"id"=>"M14473", "name"=>"Psychotic Disorders", "relevance"=>"LOW"}], "browseBranches"=>[{"name"=>"Substance Related Disorders", "abbrev"=>"BC25"}, {"name"=>"Behaviors and Mental Disorders", "abbrev"=>"BXM"}, {"name"=>"All Conditions", "abbrev"=>"All"}]}, "interventionBrowseModule"=>{"meshes"=>[{"id"=>"D000009538", "term"=>"Nicotine"}], "ancestors"=>[{"id"=>"D000005731", "term"=>"Ganglionic Stimulants"}, {"id"=>"D000001337", "term"=>"Autonomic Agents"}, {"id"=>"D000018373", "term"=>"Peripheral Nervous System Agents"}, {"id"=>"D000045505", "term"=>"Physiological Effects of Drugs"}, {"id"=>"D000018722", "term"=>"Nicotinic Agonists"}, {"id"=>"D000018679", "term"=>"Cholinergic Agonists"}, {"id"=>"D000018678", "term"=>"Cholinergic Agents"}, {"id"=>"D000018377", "term"=>"Neurotransmitter Agents"}, {"id"=>"D000045504", "term"=>"Molecular Mechanisms of Pharmacological Action"}], "browseLeaves"=>[{"id"=>"M12478", "name"=>"Nicotine", "asFound"=>"Assess", "relevance"=>"HIGH"}, {"id"=>"M3777", "name"=>"Ethanol", "relevance"=>"LOW"}, {"id"=>"M4029", "name"=>"Central Nervous System Stimulants", "relevance"=>"LOW"}, {"id"=>"M20796", "name"=>"Nicotinic Agonists", "relevance"=>"LOW"}, {"id"=>"M20758", "name"=>"Cholinergic Agents", "relevance"=>"LOW"}, {"id"=>"M20504", "name"=>"Neurotransmitter Agents", "relevance"=>"LOW"}], "browseBranches"=>[{"name"=>"All Drugs and Chemicals", "abbrev"=>"All"}, {"name"=>"Anti-Infective Agents", "abbrev"=>"Infe"}, {"name"=>"Central Nervous System Depressants", "abbrev"=>"CNSDep"}, {"name"=>"Central Nervous System Stimulants", "abbrev"=>"CNSSti"}]}}, "protocolSection"=>{"designModule"=>{"phases"=>["PHASE4"], "studyType"=>"INTERVENTIONAL", "designInfo"=>{"allocation"=>"RANDOMIZED", "maskingInfo"=>{"masking"=>"NONE"}, "primaryPurpose"=>"TREATMENT"}, "enrollmentInfo"=>{"count"=>500}}, "statusModule"=>{"overallStatus"=>"COMPLETED", "startDateStruct"=>{"date"=>"1997-09"}, "expandedAccessInfo"=>{"hasExpandedAccess"=>false}, "statusVerifiedDate"=>"2008-01", "completionDateStruct"=>{"date"=>"2004-01", "type"=>"ACTUAL"}, "lastUpdateSubmitDate"=>"2011-02-10", "studyFirstSubmitDate"=>"1999-11-02", "studyFirstSubmitQcDate"=>"1999-11-02", "lastUpdatePostDateStruct"=>{"date"=>"2011-02-11", "type"=>"ESTIMATED"}, "studyFirstPostDateStruct"=>{"date"=>"1999-11-03", "type"=>"ESTIMATED"}, "primaryCompletionDateStruct"=>{"date"=>"2004-01", "type"=>"ACTUAL"}}, "conditionsModule"=>{"conditions"=>["Alcoholism", "Smoking"]}, "descriptionModule"=>{"briefSummary"=>"This study will attempt to determine the best time to begin a smoking cessation program in individuals who undergo intensive treatment for alcohol dependence. The goal of this trial is to determine whether a smoking cessation program is more effective if it occurs at the same time as or after treatment for alcohol dependence. The study also will attempt to determine the effect of smoking cessation programs on the outcome of treatment for alcohol dependence."}, "eligibilityModule"=>{"sex"=>"ALL", "stdAges"=>["ADULT", "OLDER_ADULT"], "maximumAge"=>"75 years", "minimumAge"=>"21 years", "healthyVolunteers"=>false, "eligibilityCriteria"=>"Inclusion Criteria:\n\n* Meets criteria for alcohol use disorder and other drug dependence.\n* Complete first week of alcohol treatment program.\n* Current cigarette smoker (more than 5 cigarettes/day, smoking more than 1 year).\n\nExclusion Criteria:\n\n* Lifetime diagnosis of an excluding psychiatric disorder: bipolar disorder, schizophrenia or other psychotic disorder, panic disorder with or without agoraphobia, obsessive-compulsive disorder, generalized anxiety disorder, eating disorder, post- traumatic stress disorder, antisocial personality disorder, or borderline personality disorder.\n* Unable to participate in protocol due to functional deficits or severe depression.\n* Suicidal or homicidal ideation.\n* Current use of disulfiram (Antabuse) or naltrexone (Revia).\n* Current use of pipes, cigars, or smokeless tobacco and unwillingness to stop.\n* Lives more than 100 miles from alcohol treatment facility.\n* No telephone."}, "identificationModule"=>{"nctId"=>"NCT00000444", "briefTitle"=>"Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)", "organization"=>{"class"=>"FED", "fullName"=>"Minneapolis Veterans Affairs Medical Center"}, "officialTitle"=>"Timing of Smoking Intervention in Alcohol Treatment", "orgStudyIdInfo"=>{"id"=>"NIAAAJOS11124"}, "secondaryIdInfos"=>[{"id"=>"R01AA011124", "link"=>"https://reporter.nih.gov/quickSearch/R01AA011124", "type"=>"NIH"}]}, "armsInterventionsModule"=>{"interventions"=>[{"name"=>"nicotine replacement patch", "type"=>"DRUG"}]}, "contactsLocationsModule"=>{"locations"=>[{"zip"=>"55417", "city"=>"Minneapolis", "state"=>"Minnesota", "country"=>"United States", "facility"=>"General Internal Medicine, VA Medical Center", "geoPoint"=>{"lat"=>44.97997, "lon"=>-93.26384}}]}, "sponsorCollaboratorsModule"=>{"leadSponsor"=>{"name"=>"Minneapolis Veterans Affairs Medical Center", "class"=>"FED"}, "collaborators"=>[{"name"=>"National Institute on Alcohol Abuse and Alcoholism (NIAAA)", "class"=>"NIH"}]}}}
